{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:05:19Z","timestamp":1791403519900,"version":"4.3.3"},"reference-count":17,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006346","name":"Faculty of Medical and Health Sciences, University of Auckland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006346","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004375","name":"Tel Aviv University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004375","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013043","name":"Ariel University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013043","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jinf.2025.106529","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T19:12:15Z","timestamp":1749582735000},"page":"106529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["A benchmarking study of thirty-day mortality following Staphylococcus aureus or Escherichia coli bacteremia"],"prefix":"10.1016","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6028-5819","authenticated-orcid":false,"given":"Elizabeth","family":"Temkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liat","family":"Wulffhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9688-5960","authenticated-orcid":false,"given":"Timothy M.","family":"Pollington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimple","family":"Chudasama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7441-931X","authenticated-orcid":false,"given":"Vered","family":"Schechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1599-2618","authenticated-orcid":false,"given":"Amir","family":"Nutman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell J.","family":"Schwaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Carmeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2025.106529_bib1","unstructured":"National Healthcare Safety Network (2024). HAI progress reports. \u3008https:\/\/www.cdc.gov\/nhsn\/datastat\/progress-report.html#anchor_1700850695274\u3009. Accessed June 1,\u00a02024."},{"key":"10.1016\/j.jinf.2025.106529_bib2","unstructured":"European Centre for Disease Prevention and Control. Antimicrobial resistance in the EU\/EEA (EARS-Net) - Annual Epidemiological Report 2023; 2024. \u3008http:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/antimicrobial-resistance-annual-epidemiological-report-EARS-Net-2023.pdf\u3009.\u00a0Accessed November 26, 2024."},{"key":"10.1016\/j.jinf.2025.106529_bib3","unstructured":"Agency for Healthcare Research and Quality. National Healthcare Quality and Disparities Reports (2024).\u00a0\u3008https:\/\/datatools.ahrq.gov\/nhqdr?tab=data-query&dash=32\u3009.\u00a0Accessed July 16,\u00a02024."},{"issue":"1","key":"10.1016\/j.jinf.2025.106529_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jinf.2015.09.037","article-title":"Infectious disease consultation for Staphylococcus aureus bacteremia - A systematic review and meta-analysis","volume":"72","author":"Vogel","year":"2016","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2025.106529_bib5","doi-asserted-by":"crossref","first-page":"100511","DOI":"10.1016\/j.lanepe.2022.100511","article-title":"One-year mortality and years of potential life lost following bloodstream infection among adults: A nation-wide population based study","volume":"23","author":"Schechner","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.jinf.2025.106529_bib6","unstructured":"UK Health Security Agency. Thirty-day all-cause mortality following MRSA, MSSA and Gram-negative bacteraemia and C. difficile infections, 2020 to 2021; December 2021. \u3008https:\/\/assets.publishing.service.gov.uk\/media\/61b0aa9cd3bf7f055d72d758\/hcai-all-cause-fatality-report-2021.pdf\u3009. Accessed June 2, 2024."},{"issue":"2","key":"10.1016\/j.jinf.2025.106529_bib7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/1536867X0800800212","article-title":"Stata tip 63: modeling proportions","volume":"8","author":"Baum","year":"2008","journal-title":"Stata J"},{"issue":"8","key":"10.1016\/j.jinf.2025.106529_bib8","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.cmi.2022.03.015","article-title":"Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis","volume":"28","author":"Bai","year":"2022","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.jinf.2025.106529_bib9","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.cmi.2023.09.001","article-title":"A systematic review on the excess health risk of antibiotic-resistant bloodstream infections for six key pathogens in Europe","volume":"30","author":"Hassoun-Kheir","year":"2024","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1016\/j.jinf.2025.106529_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae126","article-title":"All-cause and infection-attributable mortality amongst adults with bloodstream infection-a population-based study","volume":"11","author":"Underwood","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"8","key":"10.1016\/j.jinf.2025.106529_bib11","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1093\/jac\/dkae093","article-title":"A comprehensive, predictive mortality score for patients with bloodstream infections (PROBAC): a prospective, multicentre cohort study","volume":"79","author":"De la Rosa-Riestra","year":"2024","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.jinf.2025.106529_bib12","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/cid\/ciac727","article-title":"Association between time to appropriate antimicrobial treatment and 30-day mortality in patients with bloodstream infections: A retrospective cohort study","volume":"76","author":"Van Heuverswyn","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2025.106529_bib13","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/cid\/ciae234","article-title":"Rapid diagnostic tests and Antimicrobial stewardship programs for the management of bloodstream infection: What is their relative contribution to improving clinical outcomes? A systematic review and network meta-analysis","volume":"79","author":"Peri","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2025.106529_bib14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1473-3099(20)30477-1","article-title":"Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals","volume":"21","author":"Kadri","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2025.106529_bib15","doi-asserted-by":"crossref","DOI":"10.1017\/ash.2025.4","article-title":"Standardization in the management of gram-negative bloodstream infections after implementation of a clinical care guideline at a large academic, safety-net institution: a quasi-experimental study","volume":"5","author":"Deaney","year":"2025","journal-title":"Antimicrob Steward Health Epidemiol"},{"key":"10.1016\/j.jinf.2025.106529_bib16","unstructured":"Organisation for Economic Cooperation and Development. Health at a glance 2021: OECD indicators. Hospital beds and occupancy. \u3008https:\/\/www.oecd-ilibrary.org\/sites\/ae3016b9-en\/1\/3\/5\/7\/index.html?itemId=\/content\/publication\/ae3016b9-en&_csp_=ca413da5d44587bc56446341952c275e&itemIGO=oecd&itemContentType=book\u3009.\u00a0Accessed July 21,\u00a02024."},{"issue":"10","key":"10.1016\/j.jinf.2025.106529_bib17","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.38309","article-title":"Analysis of blood culture collection and laboratory processing practices in Israel","volume":"5","author":"Temkin","year":"2022","journal-title":"JAMA Netw Open"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445325001239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445325001239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:32:24Z","timestamp":1778945544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445325001239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0163445325001239"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2025.106529","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A benchmarking study of thirty-day mortality following Staphylococcus aureus or Escherichia coli bacteremia","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2025.106529","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2025 Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}],"article-number":"106529"}}